ANTIMICROBIAL resistance (AMR) is no longer a distant or theoretical threat. Across the region, we now regularly witness ...
34m
Wockhardt jump 13% as US FDA accepts NDA for Zaynich antibiotic in key milestone for Indian pharma
Wockhardt shares surge as US FDA accepts first-ever NDA from an Indian pharma company for new antibiotic Zaynich, aimed at ...
Wockhardt's shares jumped 19.3% to ₹1,473 following the US FDA's acceptance of its antibiotic drug Zaynich's New Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback